Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$94.5M+19.3%$83.13M+20.2%$76.38M+11.9%$83.33M+42.8%$79.18M+48.4%
$32.12M+17.1%$29.19M+16.7%$30.07M+22.4%$29.32M+36.6%$27.44M+25.4%
$62.38M+20.5%$53.95M+22.2%$46.31M+6.0%$54.01M+46.3%$51.75M+64.4%
66%+0.7pp64.9%+1.0pp60.6%-3.4pp64.8%+1.6pp65.4%+6.3pp
$20.1M+14.0%$21.47M+30.9%$19.06M+26.5%$18.19M+9.3%$17.63M+0.7%
$69.67M+23.7%$65.09M+17.9%$58.3M+20.7%$59.01M+38.2%$56.3M+38.0%
$89.77M+21.4%$86.55M+20.9%$77.35M+22.0%$77.2M+30.1%$73.94M+26.8%
-$27.39M-23.4%-$32.61M-18.8%-$31.04M-57.5%-$23.19M-3.4%-$22.19M+17.3%
-29%-1.0pp-39.2%+0.5pp-40.6%-11.8pp-27.8%+10.6pp-28%+22.3pp
$842K-5.9%$818K-6.7%$894K-7.7%$919K-19.4%$895K-13.1%
-$26.77M-37.7%-$31.68M-27.8%-$19.44M+14.6%
$94K-30.9%-$43K+8.5%$136K+47.8%
-$26.86M-37.2%-$31.64M-27.9%-$29.85M-58.3%-$21.41M-2.1%-$19.58M+23.6%
-28.4%-3.7pp-38.1%-2.3pp-39.1%-11.4pp-25.7%+10.2pp-24.7%+23.3pp
-$0.47-34.3%-$0.56-24.4%-$0.53-55.9%-$0.38+5.0%-$0.35+30.0%
-$25.4M-23.3%-$30.87M-18.9%-$29.33M-60.7%-$21.57M-2.3%-$20.6M+19.4%
-26.9%-0.9pp-37.1%+0.4pp-38.4%-11.6pp-25.9%+10.3pp-26%+21.9pp
-$27.39M-23.4%-$32.61M-18.8%-$31.04M-57.5%-$23.19M-3.4%-$22.19M+17.3%

FAQ

What is PROCEPT BioRobotics Corporation's revenue?
PROCEPT BioRobotics Corporation (PRCT) generated $337.3M in revenue over the trailing twelve months, up 22.7% year over year.
Is PROCEPT BioRobotics Corporation profitable?
PROCEPT BioRobotics Corporation is not currently profitable: it reported a net loss of $109.8M over the trailing twelve months, a -32.5% net margin.
What are PROCEPT BioRobotics Corporation's profit margins?
Gross margin is 64.2% and operating margin is -33.9%, with a -32.5% net margin.
What is PROCEPT BioRobotics Corporation's earnings per share?
PROCEPT BioRobotics Corporation's diluted EPS over the trailing twelve months is $-1.94.
Where does PROCEPT BioRobotics Corporation's income statement data come from?
Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.